News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

What Did Mylan Inc. (MYL) Get for $1.6 Billion? A Vaccine Maker With a Troubled Factory


9/25/2013 7:32:53 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

What can $1.6 billion buy? If you are Mylan MYL +0.16% Laboratories, you can get Agila Specialties, a vaccine and injectables drugmaker that quickly expands the product portfolio and geographic reach. However, the acquisition is something of a package deal because it also comes with a headache – a troubled manufacturing plant with bad gloves, bugs, pools of water and sloppy cleaning procedures, among other things. These unpleasant discoveries and other violations of good manufacturing practices were noted during an FDA inspection last June, according to a newly disclosed warning letter sent by the agency to Agila offices in India.

Help employers find you! Check out all the jobs and post your resume.

Read at Forbes
Read at in-Pharma Technologist
Read at Pharmalot
Read at FDA

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES